Figure 6

Expression of TGF-β mRNA in the kidney/relative ratios of TGF-β mRNA level to those of the vehicle-treated SHR/NDmcr-cp group were estimated by RT-PCR after 12 weeks of treatment. *P<0.05 vs. WKY/Izm group, #P<0.05 vs. vehicle-treated SHR/NDmcr-cp group.